Roth Capital Has Pessimistic Outlook of MGRM Q3 Earnings

Monogram Orthopaedics Inc. (NASDAQ:MGRM – Free Report) – Investment analysts at Roth Capital dropped their Q3 2025 EPS estimates for shares of Monogram Orthopaedics in a report released on Tuesday, August 19th. Roth Capital analyst J. Wittes now forecasts that the company will post earnings per share of ($0.18) for the quarter, down from their […]

Leave a Reply

Your email address will not be published.

Previous post Northland Capmk Forecasts Hyliion’s Q3 Earnings (NYSE:HYLN)
Next post Noble Financial Has Pessimistic View of Snail Q3 Earnings